GSXAX
Price
$48.14
Change
-$0.29 (-0.60%)
Updated
Jul 13 closing price
Net Assets
398.17M
VSGAX
Price
$122.72
Change
-$1.76 (-1.41%)
Updated
Jul 13 closing price
Net Assets
47.01B
Interact to see
Advertisement

GSXAX vs VSGAX

GSXAX vs VSGAX Comparison Chart in %
View a ticker or compare two or three
VS
GSXAX vs. VSGAX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSXAX is a Hold and VSGAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSGAX has more cash in the bank: 47B vs. GSXAX (398M). VSGAX pays higher dividends than GSXAX: VSGAX (0.41) vs GSXAX (0.00). GSXAX was incepted earlier than VSGAX: GSXAX (28 years) vs VSGAX (15 years). GSXAX (1.49) is less costly to investors than VSGAX (0.07). GSXAX is a more actively managed with annual turnover of: 48.00 vs. VSGAX (24.00). GSXAX has a lower initial minimum investment than VSGAX: GSXAX (1000) vs VSGAX (3000). GSXAX annual gain was more profitable for investors over the last year : 29.25 vs. VSGAX (26.87). VSGAX return over 5 years is better than : 27.71 vs. GSXAX (10.12).
GSXAXVSGAXGSXAX / VSGAX
Total Expense Ratio1.350.071,929%
Annual Report Gross Expense Ratio1.490.072,129%
Fund Existence28 years15 years-
Gain YTD24.05217.371138%
Front Load6%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets398M47B1%
Annual Yield % from dividends0.000.41-
Returns for 1 year29.2526.87109%
Returns for 3 years56.8851.26111%
Returns for 5 years10.1227.7137%
Returns for 10 years58.81181.6032%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
POVYX34.78N/A
N/A
Putnam International Equity Y
CIVVX25.02N/A
N/A
Causeway International Value Inv
LSCNX24.00-0.10
-0.41%
Loomis Sayles Small Cap Value N
BGEKX14.35-0.18
-1.24%
Baillie Gifford International Growth K
TSCGX21.66-0.29
-1.32%
Thrivent Small Cap Growth S